Rationale for including intravenous immunoglobulin in the multidrug protocol of curative treatment of pemphigus vulgaris and development of an assay predicting disease relapse-Reference-Cited by-同舟云学术

Rationale for including intravenous immunoglobulin in the multidrug protocol of curative treatment of pemphigus vulgaris and development of an assay predicting disease relapse

Published:2020-05 Issue: Volume:82 Page:106385
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Grando Sergei A.,Rigas Michael,Chernyavsky Alex

Funder

Dysimmune Diseases Foundation

University of California-Irvine

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference63 articles.

1. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion;Pisanti;Oral Surg. Oral Med. Oral Pathol.,1974

2. Pemphigus: analysis of 1209 cases;Chams-Davatchi;Int. J. Dermatol.,2005

3. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases;Daoud;Int. Immunopharmacol.,2006

4. Retrospective analysis of a single‐center clinical experience toward development of curative treatment of 123 pemphigus patients with a long‐term follow‐up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion‐protecting drugs

5. French study group on autoimmune bullous skin, First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial;Joly;Lancet,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoring immune tolerance in pemphigus vulgaris;Proceedings of the National Academy of Sciences;2024-01-23

2. Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center;Medicina;2023-07-07

3. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy;Experimental Dermatology;2023-05-07

4. Chronic exposure to the anti-M3 muscarinic acetylcholine receptor autoantibody in pemphigus vulgaris contributes to disease pathophysiology;Journal of Biological Chemistry;2022-03